Bioviva

BioViva USA Inc. is a biotechnology company dedicated to developing and licensing gene therapies and procedures for cell degeneration and genetic diseases. It provides treatments in areas such as atherosclerosis, adeno-associated virus, adrenoleukodystrophy, Alzheimer's disease, diabetes, weight management, amyotrophic lateral sclerosis, Parkinson's disease, rheumatoid arthritis, and wet macular degeneration.